Information about LV Bioclin
My details
*
*
*

LV Bioclin (SRL)

BE 0538.733.743

Avenue d'Argenteuil 53, 1410 Waterloo

Company information

Status
Active

Enterprise number

BE0538.733.743

VAT liability
No
Established
18-09-2013
Last balance sheet year
2024
Company size
Micro 0 FTE
Principal activity
Medical laboratory and imaging activities
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

Try for free Discover more

7-day free trial, no credit card required.

Financial data from LV Bioclin

2024 2023 2022 2021
Profit/Loss € 214,001 42 % € 151,170 -6 % € 161,632 41 % € 114,698
Equity € 24,995 4 % € 23,995 5 % € 22,824 0 % € 22,793
Gross margin € 286,186 41 % € 202,931 -7 % € 217,841 45 % € 150,651

Publications from LV Bioclin

Date Publication
28-09-2020 Modification Legal Form - Resignations, Appointments (FR)
11-01-2016 Registered Office (FR)
20-09-2013 Rubric Constitution (New Juridical Person, Opening Branch, etc...) (FR)

Frequently asked questions

What is the enterprise number of LV Bioclin?
The enterprise number of LV Bioclin is BE 0538.733.743.
Wat is the PEPPOL ID of LV Bioclin?
There is no information available about the PEPPOL ID of LV Bioclin or the company is not yet registered on the PEPPOL network.
When was LV Bioclin founded?
LV Bioclin was founded on 18-09-2013.
What is the address of LV Bioclin?
The current registered office of LV Bioclin is located at Avenue d'Argenteuil 53, 1410 Waterloo.
When was the last time LV Bioclin filed their annual financial statements?
The most recent financial statements of LV Bioclin were filed on 22-08-2025.
How many employees does LV Bioclin have?
There are currently no employees working at LV Bioclin or no workforce information is available.
What is the annual turnover of LV Bioclin?
At the time of its most recent financial statements, LV Bioclin did not publish any turnover figures. LV Bioclin reported a gross margin of €286,185.56.

Sources